NPF marks second annual GPP Awareness Day

The National Psoriasis Foundation is recognizing Aug. 13, 2026, as GPP Awareness Day to spotlight generalized pustular psoriasis, a rare and potentially life-threatening form of psoriasis. The campaign aims to improve symptom recognition, diagnosis and treatment among patients and health care professionals.

Why it matters: - Generalized pustular psoriasis is a serious inflammatory disease with sudden, painful flares that can be life-threatening. - Even a mild flare can cause extreme pain and discomfort. - NPF says quick, accurate diagnosis is essential because GPP can require hospitalization and emergency care and can also be chronic and recurring. - The awareness effort is meant to help patients and health care professionals recognize GPP sooner and support proper treatment.

What happened: - The National Psoriasis Foundation is recognizing Aug. 13, 2026, as the second annual GPP Awareness Day. - The day is meant to remind people about generalized pustular psoriasis and educate health care professionals on diagnosis and treatment. - NPF is using the day to direct people to its GPP Resource Center for signs, symptoms and treatment information. - GPP Awareness Day is made possible with support from LEO Pharma.

The details: - GPP is a distinct form of psoriasis and is different from plaque psoriasis. - NPF describes GPP as a true dermatologic emergency. - Janene Tirado, who lives with GPP, said, “GPP can blow up your life.” - Tirado added, “While it is rare, I’m proof that GPP happens.” - LEO Pharma’s Lukasz Jarzyna said the company is partnering with NPF to elevate awareness on behalf of people living with the disease. - Jarzyna said the effort is meant to drive recognition of GPP symptoms, support timely care and deepen understanding of patient challenges. - NPF says it is the leading nonprofit representing people with psoriasis and psoriatic arthritis. - NPF says its mission is to drive efforts to cure psoriatic disease and improve the lives of more than eight million people in the U.S. affected by the chronic immune-mediated disease. - More information is available at psoriasis.org.

Between the lines: - The campaign is trying to close a knowledge gap around a rare condition that can look urgent, progress quickly and be mistaken for other skin diseases. - Partner support from LEO Pharma gives the awareness day broader reach, but the core message remains patient education and faster diagnosis.

What's next: - NPF is urging people to learn the signs and symptoms of GPP during the awareness day. - The organization is also pushing continued education around chronic management, not just flare response. - The GPP Resource Center remains the main destination for more information and support.

The bottom line: - NPF is using GPP Awareness Day to push earlier recognition of a rare psoriasis subtype that can become a medical emergency fast.